Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659)
Clinical trial NCT03382600 · COMPLETED
Trial details
- NCT number
- NCT03382600
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2021-05-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.